Dr. Jean Bourbeau, McGill University, Montréal, QC

Learning Objectives
At the end of this session, participants will be able to:

  • understand recent updates to the CTS Pharmacotherapy in patients with COPD evidence-based recommendations;
  • integrate recommendations for maintenance pharmacotherapy to improve symptoms and quality of life and reduce frequency and severity of AECOPD; and
  • discuss Canadian approach and Pharmacotherapy recommendations for COPD patients in view of the recent GOLD update 2019.